If you wish to speak to a public hearing/general business item, please refer to
notice at the beginning of this agenda. Each speaker is limited to a maximum of
three minutes. For land-use items, applicants are limited to a maximum of 10
minutes for opening comments and 5 minutes for closing comments.
Forward Recommendation to City Council to Approve the
Non-Residential Housing Mitigation Fee Nexus Study and Adopt a
Resolution Amending the Housing Impact Fee for Non-Residential
Development (Study Issue) and Find the Actions are Exempt from the
California Environmental Quality Act pursuant to CEQA Guidelines
Section 15378 (b)(4)
2.
Recommendation:
Alternatives 1 and 3: Recommend that the City Council
Approve the Non-Residential Housing Mitigation Fee Nexus
Study and Adopt a Resolution Amending the Housing Impact
Fee for Non-Residential Development for Office/R&D
Development to Increase the Fee to $11 per Square Foot for
the First 25,000 Square Feet and $22 per Square Foot for All
Remaining Square Feet, Adjusted Annually for Inflation, with
No Changes to the Fee Schedule for Retail, Lodging, and
Industrial.
Proposed Project:
Related applications on a 0.93-acre site:
3.
USE PERMIT for a new six-story hotel with 152 rooms, and
VARIANCE to allow 14.5% parking lot shading where a
minimum of 50% is required.
Location: 1220 Oakmead Parkway (APN: 216-44-048)
File #: 2022-7080
Zoning: Industrial and Service (M-S)
Applicant / Owner: Arris Studio Architects (applicant) / BPR
Properties UCSC LLC (owner)
Environmental Review: The project is consistent with the Land Use
and Transportation Element (LUTE) of the City’s General Plan and no
additional environmental review is required pursuant to CEQA
Guidelines Section 15183 and Public Resources Code Section
21083.3.
Project Planner: Kelly Cha, (408) 730-7408, kcha@sunnyvale.ca.gov
Recommendation:
Alternative 1: Make the findings required to approve the
CEQA determination that the project is consistent with the
City's General Plan and no additional environmental review is
required as noted in the checklist in Attachment 5, and
approve the Use Permit and Variance based on the
Recommended Findings in Attachment 3, and Recommended
Conditions of Approval in Attachment 4.
Selection and Ranking of Potential 2023 Study Issues
4.